Dr. Marianne Hom-Tedla, MD

Dr. Hom-Tedla practices at Los Angeles General Medical Center in Los Angeles, California, part of County of Los Angeles.

Dr. Hom-Tedla's NPI, 1972047397, was assigned on December 5, 2016. Dr. Hom-Tedla holds Pennsylvania license MD481850.

Dr. Hom-Tedla's primary practice is Los Angeles General Medical Center, at 2051 Marengo St, Room C2K100, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 226-2800.

Dr. Hom-Tedla's primary practice is Los Angeles General Medical Center in Los Angeles, California, part of County of Los Angeles. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Hom-Tedla to 2 more medical groups, 1 group practice or clinic and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hom-Tedla practices, 3 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Hom-Tedla's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Hom-Tedla is licensed in Pennsylvania.

CMS data shows 600 Medicare services from Dr. Hom-Tedla across 10 procedure codes in 2024, for 147 Medicare patients. Medicare paid $56,592 for them.

CMS counts 147 Medicare patients who saw Dr. Hom-Tedla in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hom-Tedla's median patient age at 58, with 99% women.

In 2024, Dr. Hom-Tedla wrote 189 Medicare Part D claims for 89 patients. 95% of them were for generic drugs. CMS names the drug for 56 of them, across 3 drugs with 11 or more claims each, at $207 in total drug cost. In 2023, CMS named 23 claims across 1 drug.

Dr. Hom-Tedla accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Hom-Tedla, published from 2021 to 2025. 2022 was the busiest year, with 2. The most frequent topics are Endometrial Neoplasms. Dr. Hom-Tedla has published most often in Gynecol Oncol. Dr. Hom-Tedla's most frequent co-authors are Ramez Nassef Eskander, MD, Allison Lynn Brodsky, MD and Oluwole O. Fadare, MD.

CMS Open Payments shows 43 general payments to Dr. Hom-Tedla from 16 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $381.